14 Mar 2022
MENARINI DIAGNOSTICS DETECTS ALL COVID VARIANTS
Menarini’s novel CoronaMeltVAR test detects SARS CoV-2 and discriminates the potential presence of the Delta, Omicron BA.1 or Omicron BA.2 variants
FLORENCE, Italy, March 14th, 2022 - The sub-variant Omicron 2 (BA.2), similar in some parts to the Omicron variant and in other parts to the Delta variant, is the subject of epidemiological studies and possibly of clinical relevance for the prescription of monoclonal antibodies to COVID-19 patients.
CoronaMeltVAR is a Real Time PCR molecular kit designed to detect positivity to any variant of SARS CoV-2 and simultaneously determine the presence of certain classes of variants. Based on the melting curve analysis principle, this system produces a "profile" or fingerprint of the viral genome, related to the Omicron and Delta variants.
In just 90 minutes, the kit can differentiate the potential presence of the Delta, Omicron BA.1 or Omicron BA.2 variants in a SARS CoV-2 positive sample with a single amplification and subsequent analysis of the melting curve, even on low viral load samples.
This rapid and cost effective pre-screening allows sequencing attention to be focused on samples already classified as suspicious, facilitating the in-depth investigation of the spread and pathogenicity of rare variants in the population such as, at present, the Omicron 2 (BA.2) variant.
All the samples thus classified into categories by the CoronaMeltVAR kit can then be confirmed by sequencing for an accurate definition of the molecular variant.
For more information, please visit here
A.Menarini Diagnostics, the Human Touch of Technology: more than 45 years dedicated to helping healthcare professionals make safe and sustainable diagnosis, improving the quality of life of people all over the world.
A.Menarini Diagnostics is part of the Menarini Pharmaceutical Group, founded in 1886. Today it is present in 140 countries throughout the world, it counts more than 17,000 employees and has a 2020 turnover of € 3.750 billion.